Summary by Futu AI
On October 22, 2024, a Schedule 13G filing was made with the U.S. Securities and Exchange Commission by 3i, LP, 3i Management LLC, and Maier Joshua Tarlow, collectively reporting a shared voting and dispositive power over 1,260,000 shares of BioVie Inc.'s Class A common stock. This stake represents 7.6% of the company's issued shares, based on the 16,612,374 shares outstanding as reported in BioVie's prospectus supplement dated October 23, 2024. The filing indicates that the shares are beneficially owned by 3i, LP and that 3i Management LLC, as the general partner and manager of 3i, LP, along with Maier Joshua Tarlow, as the manager of 3i Management LLC, have shared power to vote and dispose of the shares. The reporting persons have entered into a Joint Filing Agreement, indicating that they will file jointly for any subsequent amendments. The filing emphasizes that the acquisition of the shares is not for the purpose of changing or influencing the control of BioVie Inc. and is not connected with any transaction with such purpose or effect.
